Quarterly report pursuant to Section 13 or 15(d)

Unaudited Condensed Consolidated Statements of Operations

v3.21.2
Unaudited Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Income Statement [Abstract]        
Revenue $ 0 $ 0 $ 12,050 $ 0
Operating expenses:        
Research and development 4,734 8,469 11,682 18,335
Selling, general and administrative 12,774 3,357 19,468 5,966
Total operating expenses 17,508 11,826 31,150 24,301
Loss from operations (17,508) (11,826) (19,100) (24,301)
Other expense (income):        
Loss on extinguishment of debt 0 806 2,725 806
Amortization of debt issuance costs and discount 269 321 525 599
Interest income (6) (36) (12) (183)
Interest expense 445 319 659 529
Other income (3) (60) (2) (405)
Other expense 0 602 0 602
Warrant liabilities fair value adjustment (15,271) (3,560) (16,567) (8,329)
Derivative liabilities fair value adjustment (462) (693) (372) (1,393)
Total other income (15,028) (2,301) (13,044) (7,774)
Loss before taxes (2,480) (9,525) (6,056) (16,527)
Income tax benefit (4,138) (3,144) (3,038) (3,144)
Net income (loss) $ 1,658 $ (6,381) $ (3,018) $ (13,383)
Net income (loss) per share attributable to common stockholders – basic        
Net income (loss) per share – basic $ 0.06 $ (0.64) $ (0.12) $ (1.35)
Net loss per share attributable to common stockholders – diluted        
Net loss per share – diluted $ (0.22) $ (0.64) $ (0.44) $ (1.35)
Weighted average common shares outstanding – basic and diluted        
Basic 26,015,292 10,009,614 25,909,457 9,877,094
Diluted 26,487,973 10,009,614 26,505,808 9,877,094